IOWA ONCOLOGY RESEARCH ASSOCIATION
[ Home ] [ Treatment ] [ Control & Prevention ] [ STAR ] [ SELECT ] [ Physicians ] [ Contact Us ] [ Helpful Links ]

Lung Cancer Research Studies

BRONCHIOALVEOLAR CARCINOMA
E1504   Phase II Study of C225 (Cetuximab) for the Treatment of Patients with Advanced Bronchioloalveolar Carcinoma (BAC) or Adenocarcinoma with BAC Features

ADVANCED NON-SMALL CELL
N0321    Phase I/II Study of PS-341 in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)

N0528    A Randomized Phase II Study of Gemcitabine and Carboplatin with or without AZD2181 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

N0626   A Phase II Randomized Study of Pemetrexed with Sorafenib versus Pemetrexed Alone as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (temporarily suspended)

NON-SMALL CELL
E1505    Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> 4cm)- IIIA Non-Small Cell Lung Cancer

R0617    A Randomized Phase III Comparison of Standard-Dose (60Gy) Versus High-Dose (74Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin / Paclitaxel in Patients with Stage IIIA / IIIB Non-Small Cell Lung Cancer

LIMITED SMALL CELL
C30610   Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

MESOTHELIOMA
N0623   Phase II Study of GW786034 in Patients with Malignant Pleural Mesothelioma